About: Vitamin D and COVID-19 infection and mortality in UK Biobank

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Vitamin D and COVID-19 infection and mortality in UK Biobank Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Vitamin D and COVID-19 infection and mortality in UK Biobank
Creator	Hastie, Claire Pell, Jill Sattar, Naveed
Source	Medline; PMC
abstract	PURPOSE: Low blood 25-hydroxyvitamin D (25(OH)D) concentration has been proposed as a potential causal factor in COVID-19 risk. We aimed to establish whether baseline serum 25(OH)D concentration was associated with COVID-19 mortality, and inpatient confirmed COVID-19 infection, in UK Biobank participants. METHODS: UK Biobank recruited 502,624 participants aged 37–73 years between 2006 and 2010. Baseline exposure data, including serum 25(OH)D concentration, were linked to COVID-19 mortality. Univariable and multivariable Cox proportional hazards regression analyses were performed for the association between 25(OH)D and COVID-19 death, and Poisson regression analyses for the association between 25(OH)D and severe COVID-19 infection. RESULTS: Complete data were available for 341,484 UK Biobank participants, of which 656 had inpatient confirmed COVID-19 infection and 203 died of COVID-19 infection. 25(OH)D concentration was associated with severe COVID-19 infection and mortality univariably (mortality per 10 nmol/L 25(OH)D HR 0.92; 95% CI 0.86–0.98; p = 0.016), but not after adjustment for confounders (mortality per 10 nmol/L 25(OH)D HR 0.98; 95% CI = 0.91–1.06; p = 0.696). Vitamin D insufficiency or deficiency was also not independently associated with either COVID-19 infection or linked mortality. CONCLUSIONS: Our findings do not support a potential link between 25(OH)D concentrations and risk of severe COVID-19 infection and mortality. Randomised trials are needed to prove a beneficial role for vitamin D in the prevention of severe COVID-19 reactions or death.
has issue date	2020-08-26(xsd:dateTime)
bibo:doi	10.1007/s00394-020-02372-4
bibo:pmid	32851419
has license	cc-by
sha1sum (hex)	64705f4ba0d99cb221ac9c7aaac94217c4800d44
schema:url	https://doi.org/10.1007/s00394-020-02372-4
resource representing a document's title	Vitamin D and COVID-19 infection and mortality in UK Biobank
has PubMed Central identifier	PMC7449523
has PubMed identifier	32851419
schema:publication	Eur J Nutr
resource representing a document's body	covid:64705f4ba0d99cb221ac9c7aaac94217c4800d44#body_text
is schema:about of	named entity 'risk' named entity 'concentration' named entity 'COVID-19' named entity '25-hydroxyvitamin D' named entity '2010' named entity 'COVID-19' named entity 'INCLUDING' named entity 'REGRESSION ANALYSES' named entity 'CONFOUNDERS' named entity 'VITAMIN D INSUFFICIENCY' named entity 'RISK' named entity 'OUR' named entity 'SERUM' named entity 'PERFORMED' named entity 'DIED' named entity 'COX PROPORTIONAL HAZARDS REGRESSION' named entity 'independently' named entity 'infection' named entity 'UK Biobank' named entity 'linked' named entity 'beneficial' named entity 'COVID-19' named entity 'UK Biobank' named entity 'Low blood' named entity '25(OH)D' named entity 'causal factor' named entity 'COVID-19 infection' named entity '25(OH)D' named entity '95% CI' named entity '0.98' named entity '25(OH)D' named entity 'COVID-19' named entity 'COVID-19 infection' named entity 'Poisson regression' named entity 'Vitamin' named entity 'data collection' named entity 'NHS' named entity 'Declaration of Helsinki' named entity 'COVID-19' named entity 'record linkage' named entity 'circumstantial evidence' named entity 'obesity' named entity 'COVID' named entity '25(OH)D' named entity 'Vitamin' named entity 'COVID' named entity 'vitamin' named entity 'Open Access' named entity 'COVID' named entity 'concordance rates' named entity 'vitamin D deficiency' named entity '25(OH)D' named entity 'Creative Commons licence' named entity 'infection' named entity 'COVID-19' named entity 'infection' named entity 'Ethics' named entity 'Naveed Sattar' named entity '25(OH)D' named entity 'infection' named entity 'causal link' named entity 'follow-up' named entity 'vitamin' named entity 'Informed consent' named entity 'proportional hazards regression' named entity 'serum' named entity 'informed consent' named entity 'risk factors' named entity 'acute phase reactant' named entity '25(OH)D' named entity 'infection' named entity 'infection' named entity '25(OH)D' named entity 'vitamin' named entity 'respiratory tract infections' named entity 'vitamin' named entity 'COVID' named entity 'COVID-19' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software